Information for you
On this page, you will find information on the Agency’s activities, including news and events, that are most relevant to Animal health professionals and users of veterinary medicines such as pet owners.
You can contribute to the Agency’s work by responding to public consultations.
Learn more about the European Medicines Agency's Committee for Medicinal Products for Veterinary Use (CVMP) and its role regarding medicines for veterinary use.
Consultation on revised guidelines on data requirements for minor use, minor species (MUMS)/limited market
The revision updates the guidance in line with the experience gained over the last 10 years in setting appropriate data requirements for the quality, safety and efficacy for pharmaceutical products, and separately for immunologicals. The consultation runs for six months from January 2016.
Veterinary medicines highlights 2015
EMA has released an overview of its key recommendations in 2015 on the authorisation of new veterinary medicines and the safety monitoring of authorised medicines. EMA recommended 14 veterinary medicines for marketing authorisation, half of which contain a new active substance.
Vaccines against epizootic diseases
The EMA Management Board agreed financial incentives to support the availability of veterinary vaccines against certain epizootic diseases, such as bluetongue and foot and mouth disease, by waiving maintenance fees in the absence of sales and when specified criteria are met. See page 43 of the explanatory note on fees payable to the Agency. This initiative supports the principle of “prevention is better than cure” outlined in the European Commission’s Animal Health Strategy (2007-2013).
Finding Maximum Residue Limits (MRLs)
A maximum residue limit (MRL) is the maximum acceptable concentration of an active substance that may be found in a food product obtained from an animal that has received a veterinary medicine. You can search or browse by substance for information on specific MRLs.
The Agency works with its partners to raise awareness of antimicrobial resistance in the European Union.
News for animal health professionals
EMA-HMA action plan published along with new webpage ... Read more
Goal is to cut colistin sales by 65% ... Read more
- See all News for animal health professionals
Events of interest
Veterinary focus group meeting with stakeholders: revision of the reflection paper on anthelmintic resistance
The focus group meeting aims to facilitate the exchange of views from regulators, industry, research and veterinarians as part of the public consultation process on the revised draft reflection paper on anthelmintic resistance (CVMP/EWP/573536/2013-Rev.1). The Efficacy Working Party of the Committee for Medicinal Products for Veterinary Use (CVMP) revised the first version of the draft reflection paper to take into account comments received during public consultation. The CVMP adopted the revised reflection paper in April 2016 and released it for a second public consultation until 31 July 2016. ... Read more
The CVMP will be holding an interested parties meeting as part of regular stakeholder liaison. Topics for discussion this year will include MUMS and JEG 3R (replacement, reduction and refinement), availability of veterinary medicines antimicrobials resistance and discussion on operational excellence. ... Read more
17/03/2016 - 18/03/2016
The info day covers the latest developments in the scientific review, regulation and marketing authorisation procedure. It is an opportunity for professionals to get first-hand information on current developments in the veterinary regulatory scene. Registration open. ... Read more
The annual European Surveillance of Veterinary Antimicrobial Consumption (ESVAC) stakeholders annual meeting 2016
The annual European Surveillance of Veterinary Antimicrobial Consumption (ESVAC) meeting for stakeholders held on 2 March 2016 was organised by the European Medicines Agency to inform European Union Member States, stakeholders and observers on latest activities related to collection of data of veterinary antimicrobials and on the draft ESVAC strategy 2016-2020 and also to share information on activities for the containment of antimicrobial resistance. ... Read more
The CVMP will be holding an interested parties meeting as part of regular stakeholder liaison. Subjects for discussion will include pharmacovigilance, environmental risk assessment, SPC harmonisation and measures taken to promote the 3 Rs (replacement, reduction and refinement). Registration by invitation only. ... Read more
- See all Events of interest